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Further chemical investigation of two Ligularia virgaurea samples collected in China resulted in 
the isolation of 21 new compounds, two of which were bakkane-type sesquiterpenoids bearing an 
anhydride-type ring C, which was a previously unknown partial structure. These samples 
belonged to the V-type (the major component was virgaurenone) among the five chemotypes 









Ligularia (Asteraceae) is a highly diversified genus in the Hengduan Mountain region of China, 
and we have expressed the presence of intra-specific diversity in many species in terms of both 
the chemical composition and DNA sequence of an evolutionarily neutral region.1 Ligularia 
virgaurea (Maxim.) Mattf. is an abundant species in the western area of the Sichuan province. 
We previously reported that the species collected in the Sichuan, Qinghai, and Gansu provinces 
were grouped into the following five chemotypes on the basis of their terpenoid constituents: 
L-type (the major component was ligularol), V-type (virgaurenone A), C-type (cacalol), H-type 
(6-hydroxyeuryopsin), and N-type (neoadenostylone).2-4 The species were grouped into three 
clades on the basis of their DNA sequences, which were in good agreement with the chemotypes 
(clade A = L-type, clade B = V- and H-types, clade C = C- and N-types). In addition to 
furanoeremophilanes, the major components, we previously isolated a variety of new compounds 
such as seco-eremophilanes, bakkanes, and compounds having further rearranged carbon 
skeletons from 38 samples of L. virgaurea.3 Various sesquiterpene dimers were also isolated.3-7 
Since then, four new compounds, including rearranged norsesquiterpenes, were characterized 
from another sample.8 We have analyzed two more samples (one from northern Sichuan province 
and the other from southern Gansu province)3 and 26 compounds were isolated, 21 of which 
were new. Two of these compounds have a unique structure, a bakkane bearing an anhydride 




Figure 1. Compounds isolated in this study (asterisks indicate new compounds). 
 
2. Results and Discussion 
Compound 1 exhibited a quasi-molecular ion peak at m/z 361, and its molecular formula was 
determined to be C20H24O6 by HRCIMS and 13C NMR data. An angelate moiety was apparent 
from chemical shift values of δ 5.61 (1H, qq, J = 7.3, 1.5 Hz), 1.87 (3H, dq, J = 7.3 and 1.5 Hz), 
and 1.69 (3H, quintet, J = 1.5 Hz) (Table 1) as well as an IR absorption band at 1722 cm-1. The 
IR absorption at 1850 cm-1 indicated the presence of any of an epoxy-lactone, an enol-lactone, or 
an anhydride. The observed value was at a slightly higher wavenumber than that at which an 
epoxy- and an enol-lactone have ever been encountered.2,3,8 The 13C NMR spectrum indicated 
the presence of five methyl, two methylene, five methine, and eight quaternary carbon atoms 
including eight sp2 carbon atoms (four carbonyl and four olefinic carbons). The degree of 
unsaturation was 9, and therefore, this compound should be tricyclic. The 2D correlations are 
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shown in Fig. 2. The HMBC correlations between H3-15 and C-3 and 4, between H3-14 and C-4, 
5, 6, and 10, between H-3 and C-2, and between H-9 and C-1 suggested a six-membered 
carbocycle for ring A. Because H-6 showed a correlation with C-7 (quaternary carbon), H-9 with 
C-8 (carbonyl), and H-11 with C-7, this compound was deduced to be a bakkane derivative. Both 
carbons C-8 and 12 were carbonyl groups; therefore, ring C must be an anhydride, as shown in 
Fig 2. The angeloyloxy group was substituted at C-6 as indicated by the correlation between H-6 
and C-1'. The stereochemistry was determined by the NOESY correlations shown in Fig. 2. 
Because the NOE between H3-14 and H-3β was observed, the conformation of ring A should be 
C-3 up and C-4 down as shown. The NOEs between H-6 and H-4 and between H3-14 and H3-15 
indicated that both H-6 and H-4 were α. The stereochemistry at C-7 was determined by the NOE 
between H-6 and H3-13. Thus, C-11 was established to be down, and the methyl group at C-11 
was established to be up (Fig. 2).  
This is the first example of a bakkane-type sesquiterpenoid bearing an anhydride partial structure. 
This is presumably derived from the corresponding epoxide by rearrangement. This compound 
was named virgaureno-anhydride A. 
 
Figure 2. Selected 2D correlations detected for compound 1. 
 
Compound 2 exhibited similar spectroscopic features to those of compound 1, except that an 
angelate moiety was not present and an acetyl methyl signal was observed in this compound 
(Table 1). The molecular formula was determined to be C17H20O6 by HRCIMS and 13C NMR 
data. The presence of an anhydride was suggested by the IR absorption bands at 1848 and 1780 
cm-1. The 2D correlations are shown in Fig. 3, which were very similar to those of compound 1. 
An acetyl group was suggested to be at C-6 due to the correlation between H-6 and C-1'. The 
difference from compound 1 was the stereochemistry of C-7. The NOE between H3-13 and H-9β 
and between H-11 and H3-14 indicated that the C-8 carbonyl carbon must be down, and the 
methyl group at C-11 must also be down. The configuration of the methyl group at C-11 needs to 
be commented on. From the biosynthetic discussion, H3-13 should be up (vide infra). However, 
this was established to be down. Therefore, the configuration at C-11 was presumably isomerized 
by the effect of a bulky substituent present at C-6 close to this methyl group at a later stage of 
biosynthesis. This compound was named virgaureno-anhydride B. 
 
Figure 3. Selected 2D correlations detected for compound 2. 
 6 
 
Compounds 3−5 showed similar spectroscopic features to those of compounds 1 and 2 (Table 2). 
The molecular formulae of compounds 3, 4, and 5 were C20H24O6, C17H20O6, and C15H18O5, 
respectively, based on HRCIMS and 13C NMR data. The differences between these three 
compounds were the substituents at C-6, namely there is an angelate in 3, an acetate in 4, and no 
acyl group in 5, as suggested by their 1H NMR spectra (Table 2) and molecular formulae. The 2D 
correlations are shown in Fig. 4, and these three compounds had a bakkane skeleton with a 
1(10)-en-2-one system. The stereochemistry was suggested by the NOESY correlations to be a 
C-8 down structure for the spiro carbon at C-7. The epoxide ring must be up because the NOE 
between H3-13 and H-9β was observed. Compounds 3−5 were named virgaurenospirolides A-C, 
respectively. 
 
Figure 4. Selected 2D correlations detected for compounds 3−5. 
 
Compounds 6−9 had similar spectroscopic data to each other. The molecular formulae of 
compounds 6−9 were C20H24O5, C17H20O5, C15H18O4, and C19H24O5, respectively. Seven sp2 
carbon atoms (including one carbonyl) were detected for compound 8. The degree of 
unsaturation was 7, and therefore, compound 8 should be tricyclic. The 2D correlations are 
shown in Fig. 5, indicating the presence of a triene-2-one partial structure substituted with two 
hydroxy groups at C-6 and 12. Compounds 6, 7, and 9 had the same partial structures with esters 
at C-6 (compound 6 with an angelate, 7 with an acetate, and 9 with an isobutyrate). The 
stereochemistry of the acyloxy or hydroxy group at C-6 was suggested to be β; however, the 
configuration at C-12 was not determined. Compounds 6, 7, and 9 were isolated in only one 
isomer, being either OH-12 α or β; meanwhile, compound 8 existed in both forms, although the 
C-12 stereochemistry was unclear (Table 3). Compounds 6−9 were named virgaurenolidols A-D, 
respectively. 
 
Figure 5. Selected 2D correlations detected for compounds 6−9. 
 
Compounds 10−12 were derivatives of virgaurenolides, with all of them having the same 
skeleton of a triene-2,12-dione structure with a different acyloxy or hydroxy group at C-6 (Fig. 6 
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and Table 4). Compounds 11 and 12 were isolated in almost a 1:1 mixture and analyzed without 
further separation. The stereochemistry at C-6 was established by the NOE between H-6α and 
H-4α and between H3-14 and H3-15 (Fig. 6). Compounds 10−12 were named virgaurenolides 
C-E, respectively. 
 
Figure 6. Selected 2D correlations detected for compounds 10−12. 
 
The molecular formulae of compounds 13−16 were determined to be C20H24O6, C19H24O6, 
C17H20O6, and C15H18O5, respectively by HRCIMS and 13C NMR data. All compounds exhibited 
an IR absorption band at approximately 1809 cm-1 and were deduced to be an epoxy- or an 
enol-lactone,2,3,8 which was supported by the presence of quartet signals at δ 2.49-2.83 (J = 
7.1-7.3 Hz) assignable to H-11 in the 1H NMR spectra (Table 5). The 2D correlations shown in 
Fig 7 indicated that these compounds were epoxy-lactones with 1(10)-en-2-one structures. The 
oxygen functional groups substituted at C-6 were an angeloyloxy, an isobutyroyloxy, an acetoxy, 
and a hydroxy group for compounds 13−16, respectively. The stereochemistry was established as 
shown in Fig. 7 by the NOE between H-6α and H-4α and between H-6α and H3-13 in each 
compound. If the epoxide ring was β, these NOEs could not feasibly to be detected.3 In the case 
of compound 17, the molecular formula was the same as that of compound 15, and the 
spectroscopic features were very similar to those of compound 15. The 2D correlations shown in 
Fig. 8 indicated that this compound had the same planar structure as that of 15. However, the 
quartet proton was detected at δ 2.38 (J = 7.1 Hz, H-11), which was slightly higher field than for 
15 (Table 5). The configuration at C-11 was established by the NOESY correlations between 
H-6α and H-4α and between H-6α and H-11α. Therefore, compound 17 was established to be 
11αH-7β,8β-epoxy-2-oxoeremophil-1(10)-en-12,8-olide. 
 
Figure 7. Selected 2D correlations detected for compounds 13-16. 
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Figure 8. Selected 2D correlations detected for compound 17. 
 
Three compounds, 18−20, had molecular formulae of C20H24O6, C17H20O6, and C15H18O5, 
respectively. The 1H and 13C NMR data indicated that these three had a 1(10)-en-2-one system 
(Table 6) and a γ-lactone (see Experimental). The 2D correlations for these compounds suggested 
that they had an eremophilenolide skeleton with a 1(10)-en-2-one partial structure and oxygen 
functional groups at C-6 and 8 (Fig. 9). The stereochemistry was determined by the NOE 
between H3-14 and H-9β and between H-6α and H-4α, indicating that the hydroxy group at C-8 
should be α. If this group was β, the conformations of rings A and B should be different from 
those observed, as previously discussed.2,3,8  
 
Figure 9. Selected 2D correlations detected for compounds 18-20. 
 
The IR spectrum of the final compound 21 showed absorption bands at 1720 and 1672 cm-1. The 
13C NMR data exhibited the presence of five methyl, one methylene, five methine, and nine 
quaternary carbon atoms, including three carbonyl and eight olefinic carbons. The molecular 
formula was C20H22O5 (by HRMS and 13C NMR), and therefore, this was determined to be a 
tricyclic compound. The 1H and 13C NMR data suggested the presence of a furan (Table 6), and a 
furanoeremophilane skeleton was shown by the 2D correlations (Fig. 10). One carbonyl (δ 
196.3) was placed at C-2, and the other one (δ 173.1) was not indicated by the HMBC 
correlations. However, the position of this carbonyl group at C-9 was best explained based on the 
spectroscopic data. A similar discussion was reported for all of the 9-oxofuranoeremophilane 
compounds ever isolated.9-12 The angeloyloxy group was substituted at C-6 as indicated by the 
chemical shift (δH 6.11, δC 72.1) (Table 6). The NOE between H-6α and H-4α indicated the 
stereochemistry for this compound.  
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Figure 10. Selected 2D correlations detected for compound 21. 
 
The absolute configurations of the compounds isolated in this work were studied by CD spectra. 
Most of the compounds had a 1(10)-en-2-one system, with some of them having a 
1(10),7(11),8-triene-2,12-dione or a 1(10),7(11),8-triene-2-one system. The CD spectra of 
compounds with such a system resembled each other, namely, a positive Cotton effect at 
approximately 240-250 nm and a negative Cotton effect at approximately 300-340 nm for a 
1(10)-en-2-one system (see Experimental). The enone chirality rule13 was not easy to apply for 
these compounds because the distortion of the carbonyl and the olefin was not sufficiently large 
to predict the sign of the Cotton effect. Therefore, DFT calculations were carried out for 
compound 5. The results of the calculations and the experimental CD spectra are shown in Fig. 
11. These results were quite similar to each other, and the absolute configuration of compound 5 
was established as depicted in the formula. Hence, other compounds isolated here were deduced 
to have the same absolute configuration as that of compound 5. 
 
Figure 11. The CD spectra of compound 5 (red: observed; blue: calculated). 
 
Other compounds were virgaurenone A (22), virgaurenone B (23), virgaurenolide A (24), 
virgaurenolide B (25), and fukinospirolide B (26) (Fig. 1). The major constituent of sample 1 
(2010-63) was virgaurenone B (23) (10.1% of the extract), and that of sample 2 (2010-68) was 
virgaurenolidol A (6) (6.1% of the extract). As previously reported,3 these two samples belong to 
the V-type (a group consisting of virgaurenone and virgaurenolide derivatives). 
Virgaureno-anhydrides, 1 and 2, were new type of compounds, which had a cyclic anhydride 
moiety, a hitherto unknown partial structure in the bakkane skeleton. Lactols have been isolated 
from Ligularia plants, two precedents of which had oxygen functional groups both at C-8 and 
C-12.14,15 Virgaurenolidols, 6−9, correspond to a reduced-type of virgaurenolide. 
 
Finally, it might be worth discussing plausible biosynthetic pathways. Plausible biosynthetic 
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compounds may be produced by ring opening of an epoxide ring (rearrangement) leading to 1 
from 27 (Fig. 12). However, in the case of virgaureno-anhydride B (2), when the epoxide ring of 
compound 4 rearranged, H3-13 should be up because the hydride attacked from the backside at 
C-11 resulting in H3-13 being up. Therefore, the configuration at C-11 could best be explained by 
isomerization at a later stage of biosynthesis due to a bulky substituent at C-6 close to this 
position (vide supra). 
 
Figure 12. Plausible biosynthetic pathways for virgaureno-anhydrides A (1) and B (2). 
 
3. Conclusions 
We have isolated 26 compounds from two species of L. virgaurea collected in China (one from 
northern Sichuan province and the other from southern Gansu province). New compounds 
included three virgaurenospirolides, 3−5, four virgaurenolidols A−D, 6-9, three virgaurenolides 
C−E, 10−12, five epoxy-lactones, 13−17, three lactones, 18−20, an enedione 21, and two 
anhydrides, 1 and 2. The structures of virgaureno-anhydrides, 1 and 2, were especially novel. All 
of the compounds isolated had a 1(10)-en-2-one system, and this partial structure was recognized 
as characteristic to this chemotype (V-type) of L. virgaurea. Absolute configurations were 













Table 3. 1H and 13C NMR data of virgaurenolidols A−D, (6)−(9) 
 
 













4.1. General  
Specific rotations and CD spectra were measured on JASCO DIP-1030 and JASCO J-725 auto 
recording polarimeters; IR spectra on a SHIMADZU FT/IR-8400S spectrophotometer (Diffuse 
reflection method on KBr); 1H and 13C NMR spectra on Varian Unity 600 (600 MHz and 150 
MHz, respectively), Varian 500-MR (500 MHz and 125 MHz, respectively), and JEOL ECP 400 
(400 MHz and 100 MHz, respectively) spectrometers. Mass spectra, including high-resolution 
spectra, were recorded on a JEOL JMS-700 MStation. Chemcopak Nucleosil 50-5 (4.6×250 mm) 
and TSK-GEL G1000HHR (7.8×300 mm) were used for HPLC with a solvent system of 
hexane-ethyl acetate. Silica gel 60 (70-230 mesh, Fuji Sylisia), Wakogel C-200 or Wakogel 
C-300 (Wako) was used for column chromatography. Silica gel 60 F254 plates (Merck) were used 
for TLC. Ehrlich’s test was carried out as previously described.2 
 
4.2. Plant materials 
See ref. 3: sample 1 corresponds to that of 20 (in Table 1 of ref 3; northern Sichuan province) 
and sample 2 to 37 (southern Gansu province). 
 
4.3. Extraction and purification for the structural determination 
The root of sample 1 (2010-15) (dry weight 7.6 g) was cut into pieces and extracted with EtOAc 
to afford an extract (554 mg). The residue was subjected to silica-gel column chromatography 
(hexane-EtOAc, gradient), followed by HPLC (Nucleosil 50-5 and TSK-GEL G1000HHR; 
hexane-EtOAc) to give 2 (1.5 mg), 4 (3.7 mg), 5 (0.5 mg), 7 (2.3 mg), 10 (0.7 mg), 13 (1.3 mg), 
15 (8.7 mg), 16 (0.8 mg), 17 (0.9 mg), 19 (2.7 mg), 22 (6.1 mg), 23 (54.5 mg), 25 (1.4 mg), and 
26 (0.6 mg),  
 
The root of sample 2 (2010-68) (dry weight 3.1 g) was cut into pieces and was extracted with 
EtOAc to afford an extract (405 mg). The residue was subjected to silica-gel column 
chromatography (hexane-EtOAc, gradient), followed by HPLC (Nucleosil 50-5 and TSK-GEL 
G1000HHR; hexane-EtOAc) to give 1 (1.4 mg), 3 (3.8 mg), 5 (1.5 mg), 6 (24.7 mg), 7 (0.7 mg), 8 
(4.5 mg), 9 (2.2 mg), 10 (2.3 mg), 11 and 12 (0.6 mg; 1:1), 13 (7.7 mg), 14 (0.5 mg), 16 (4.5 mg), 
18 (6.6 mg), 20 (1.6 mg), 21 (0.9 mg), and 24 (4.7 mg). 
 
4.4. Compound data 
1: [α]D21 −50.0 (0.10, EtOH); FTIR 1850, 1788, 1722, 1666 cm-1; MS (CI) m/z 361 [M+H]+, 333, 
261, 83 (base); HRMS (CI) Obs. m/z 361.1657 [M+H]+ (Calcd for C20H25O6 361.1651); CD [θ] 
−40000 (205 nm), +21000 (234), −4300 (327). 
 
2: [α]D21 −13.0 (0.12, EtOH); FTIR 1848, 1780, 1735, 1655 cm-1; MS (CI) m/z 321 [M+H]+, 293, 
279 (base), 233; HRMS (CI) Obs. m/z 321.1346 [M+H]+ (Calcd for C17H21O6 321.1338); CD [θ] 
−2600 (226 nm), -1400 (201), +1200 (242), −100 (330). 
 
3: [α]D21 +17.7 (0.15, EtOH); FTIR 1782, 1726, 1715, 1666 cm-1; MS (CI) m/z 361 [M+H]+ 
(base), 349, 333, 279, 233, 83; HRMS (CI) Obs. m/z 361.1651 [M+H]+ (Calcd for C20H25O6 
361.1651); CD [θ] −31000 (204 nm), +39000 (236), −2000 (358). 
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4: [α]D21 +3.2 (0.37, EtOH); FTIR 1786, 1747, 1663 cm-1; MS (CI) m/z 321 [M+H]+ (base), 279, 
278, 233, 191; HRMS (CI) Obs. m/z 321.1336 [M+H]+ (Calcd for C17H21O6 321.1338); CD [θ] 
−17000 (203 nm), +22000 (237), −1700 (344). 
 
5: [α]D22 +13.8 (0.05, EtOH); FTIR 3442, 1788, 1730, 1649 cm-1; MS (CI) m/z 279 [M+H]+ 
(base), 261, 233; HRMS (CI) Obs. m/z 279.1223 [M+H]+ (Calcd for C15H19O5 279.1233); CD [θ] 
−30000 (206 nm), +23000 (243), −2800 (336). 
 
6: [α]D21 −339 (0.05, EtOH); FTIR 3300, 1715, 1614 cm-1; MS (CI) m/z 345 [M+H]+ (base), 327, 
245, 229; HRMS (CI) Obs. m/z 345.1703 [M+H]+ (Calcd for C20H25O5 345.1702); CD [θ] 
+25000 (201 nm), +8100 (246), +2200 (266), +19000 (317), −45000 (363). 
 
7: [α]D22 −267 (0.23, EtOH); FTIR 3242, 1747, 1614, 1568 cm-1; MS (CI) m/z 305 [M+H]+ 
(base), 304, 245, 229; HRMS (CI) obs. m/z 305.1389 [M+H]+, calcd for C17H21O5 305.1389; CD 
[θ] −2600 (226 nm), +3100 (249), +12000 (318), −28000 (364). 
 
8: [α]D21 −534 (0.27, EtOH); FTIR 3275, 1605,1555 cm-1; MS (CI) m/z 263 [M+H]+ (100), 262, 
245; HRMS (CI) Obs. m/z 263.1278 [M+H]+ (Calcd for C15H19O4 263.1283); CD [θ] +62000 
(202 nm), −13000 (228), +6700 (253), +19000 (317), −60000 (362). 
 
9: [α]D21 −417 (0.2, EtOH); FTIR 3219, 1732, 1605, 1566 cm-1; MS (CI) m/z 333 [M+H]+ (base), 
329, 315, 273, 261, 245; HRMS (CI) Obs. m/z 333.1698 [M+H]+ (Calcd for C19H25O5 333.1702); 
CD [θ] +38000 (201 nm), −5600 (225), +7000 (248), +20000 (318), −52000 (365). 
 
10: [α]D22 −104 (0.072, EtOH); FTIR 1782, 1744, 1665, 1632 cm-1; MS (CI) m/z 261 [M+H]+ 
(base), 260, 245, 227, 203; HRMS (CI) obs. m/z 261.1131 [M+H]+, calcd for C15H17O4 261.1127; 
CD [θ] −11000 (202 nm), −800 (251), +750 (277), −4600 (363). 
 
11, 12 mixture: [α]D21 −458 (0.056, EtOH); FTIR 1778, 1738, 1668, 1643, 1582 cm-1; MS (CI) 
m/z 331 [M+H]+ (base), 329 [M+H]+, 261, 243; HRMS (CI) Obs. m/z 331.1538 [M+H]+ (Calcd 
for C19H23O5 331.1545 (for 11) and m/z 329.1396 [M+H]+, calcd for C19H21O5 329.1389 (for 
12); CD [θ] +52000 (202 nm), −2900 (228), −27000 (363). 
 
13: [α]D21 −7.2 (0.12, EtOH); FTIR 1809, 1730, 1682 cm-1; MS (CI) m/z 361 [M+H]+, 360, 305, 
278, 261, 245, 83 (base); HRMS (CI) Obs. m/z 361.1647 [M+H]+ (Calcd for C20H25O6 
361.1651); CD [θ] −6700 (204 nm), +14000 (232). 
 
14: [α]D20 −40.4 (0.03, EtOH); FTIR 1809, 1742, 1682 cm-1; MS (FAB) m/z 349 [M+H]+ (base), 
279, 278, 261, 233; HRMS (FAB) Obs. m/z 349.1642 [M+H]+ (Calcd for C19H25O6 349.1651); 
CD [θ] −44000 (201 nm), +22000 (240), −5200 (362). 
 
15: [α]D16 +3.78 (0.23, EtOH); FTIR 1809, 1755, 1732, 1682 cm-1; MS (CI) m/z 321 [M+H]+, 
303, 278 (100), 261; HRMS (CI) Obs. m/z 321.1330 [M+H]+ (Calcd for C17H21O6 321.1338); 
CD [θ] −20000 (207 nm), +49000 (233 nm), −1400 (337). 
 
 17 
16: [α]D21 +9.9 (0.003, EtOH); FTIR 3346, 1807, 1678, 1666 cm-1; MS (CI) m/z 279 [M+H]+ 
(base), 261, 233; HRMS (CI) Obs. m/z 279.1231 [M+H]+ (Calcd for C15H19O5 279.1232); CD [θ] 
−33000 (206 nm), +30000 (246), −2200 (340). 
 
17: [α]D21 −17.3 (0.09, EtOH); FTIR 1807, 1744, 1670 cm-1; MS (FAB) m/z 321 [M+H]+ (base), 
303, 279, 261, 233; HRMS (FAB) Obs. m/z 321.1314 [M+H]+ (Calcd for C17H21O6 321.1338); 
CD [θ] −3300 (202 nm), +1500 (235), +430 (285), −200 (360). 
 
18: [α]D20 −121.1 (0.06, EtOH); FTIR 3296, 1768, 1722, 1672 cm-1; MS (FAB) m/z 361 [M+H]+, 
307, 289, 176, 154 (base), 136; HRMS (FAB) Obs. m/z 361.1651 [M+H]+ (Calcd for C20H25O6 
361.1651); CD [θ] −28000 (206 nm), +18000 (236), −11000 (255), +5100 (316). 
 
19: [α]D23 −35.6 (0.22, EtOH); FTIR 3356, 1747, 1664 cm-1; MS (FAB) m/z 321 [M+H]+, 303 
(base), 302; HRMS (FAB) Obs. m/z 321.1330 [M+H]+ (Calcd for C17H21O6 321.1338); CD [θ] 
−16000 (204 nm), +11000 (234), −3700 (255), +2100 (319). 
 
20: [α]D20 −89.1 (0.13, EtOH); FTIR 3358, 1745, 1666 cm-1; MS (FAB) m/z 279 [M+H]+, 261, 
173, 154 (base), 136; HRMS (FAB) Obs. m/z 279.1227 [M+H]+ (Calcd for C15H19O5 279.1232); 
CD [θ] −25000 (217 nm), +22000 (240), −3000 (261), −5200 (362). 
 
21: [α]D21 −78.8 (0.05, EtOH); FTIR 1720, 1672 cm-1; MS (CI) m/z 343 [M+H]+ (base), 342, 243, 
242, 83; HRMS (CI) Obs. m/z 343.1547 [M+H]+ (Calcd for C20H23O5 343.1545); CD [θ] −13000 
(230 nm), −25000 (258), +10000 (317), −5100 (380). 
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Figure 1. Compounds isolated in this study (asterisks indicate new compounds). 
Figure 2. Selected 2D correlations detected for compound 1. 
Figure 3. Selected 2D correlations detected for compound 2. 
Figure 4. Selected 2D correlations detected for compounds 3−5. 
Figure 5. Selected 2D correlations detected for compounds 6−9. 
Figure 6. Selected 2D correlations detected for compounds 10−12. 
Figure 7. Selected 2D correlations detected for compounds 13−16. 
Figure 8. Selected 2D correlations detected for compound 17. 
Figure 9. Selected 2D correlations detected for compounds 18−20. 
Figure 10. Selected 2D correlations detected for compound 21. 
Figure 11. The CD spectra of compound 5 (red: observed; blue: calculated). 




Table 1. 1H and 13C NMR data of virgaureno-anhydrides A (1) and B (2) 
Table 2. 1H and 13C NMR data of virgaurenospirolides A-C, (3)−(5) 
Table 3. 1H and 13C NMR data of virgaurenolidols A-D, (6)−(9) 
Table 4. 1H and 13C NMR data of virgaurenolides C-E, (10)−(12) 
Table 5. 1H and 13C NMR data of compounds 13−17 
Table 6. 1H and 13C NMR data of compounds 18−21 
 
